The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High‐Dose Vancomycin Combined with Saccharomyces boulardii
Abstract
Recurrent Clostridium difficile disease (CDD) is a difficult clinical problem because antibiotic therapy often does not prevent further recurrences. In a previous study, the biotherapeutic agent Saccharomyces boulardii was used in combination with standard antibiotics and was found to be effective in reducing subsequent recurrences of CDD. In an effort to further refine a standard regimen, we tested patients receiving a regimen of a standard antibiotic for 10 days and then added either S. boulardii (1 g/day for 28 days) or placebo. A significant decrease in recurrences was observed only in patients treated with high-dose vancomycin (2 g/day) and S. boulardii (16.7%), compared with those who received high-dose vancomycin and placebo (50%; P=.05). No serious adverse reactions were observed in these patients. Comparison of data from this trial with data from previous studies indicates that recurrent CDD may respond to a short course of high-dose vancomycin or to longer courses of low-dose vancomycin when either is combined with S. boulardii.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McFarland, L. V. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510480037031 · Cited by 857
Self-citation(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Clostridium Difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/648363 · Cited by 631
Self-citationPrevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & Van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 573
Self-citationWenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
Fekety, R. (1997) · PubMed · Cited by 442
Self-citationCastagliuolo, I., Riegler, M. F., Valenick, L., LaMont, J. T., & Pothoulakis, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.302-307.1999 · Cited by 408
Clostridium difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30141083 · Cited by 398
Self-citationFekety, R., McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., & Mulligan, M. E. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.324 · Cited by 376
Self-citationRecurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics
McFarland, L. V., Surawicz, C. M., Rubin, M., Fekety, R., Elmer, G. W., & Greenberg, R. N. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501553 · Cited by 353
Self-citationOlson, M. M., Shanholtzer, C. J., Lee, J. T., & Gerding, D. N. (1994) · Infection Control & Hospital Epidemiology · doi:10.1086/646934 · Cited by 339
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K., & Cox, J. L. (1995) · PubMed · Cited by 338
Self-citationElmer, G. W. (1996) · JAMA · doi:10.1001/jama.275.11.870 · Cited by 326
Self-citationPothoulakis, C., Kelly, C. P., Joshi, M. A., Gao, N., O'Keane, C. J., Castagliuolo, I., & Lamont, J. T. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90280-p · Cited by 281
Epidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
Surawicz, C. M., McFarland, L. V., Elmer, G., & Chinn, J. (1989) · PubMed · Cited by 179
Self-citationSymptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis
Bartlett, J. G., Tedesco, F. J., Shull, S., Lowe, B., & Chang, T. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90851-3 · Cited by 169
McFarland, L. V. (1994) · JAMA · doi:10.1001/jama.271.24.1913 · Cited by 166
Self-citationSaccharomyces boulardii: A Review of an Innovative Bio therapeutic Agent
McFarland, L. V., & Bernasconi, P. (1993) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v6i4.8126 · Cited by 153
Self-citationEpidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea.
Anand, A., Bashey, B., Mir, T., & Glatt, A. E. (1994) · PubMed · Cited by 138
Rapid biochemical test to identify verocytotoxin-positive strains of Escherichia coli serotype O157
Thompson, J. S., Hodge, D. S., & Borczyk, A. A. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.10.2165-2168.1990 · Cited by 138
Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent
McFarland, L. V., & Bernasconi, P. (1993) · Microbial Ecology in Health and Disease · doi:10.3109/08910609309141323 · Cited by 133
Self-citationSaccharomyces boulardii for Clostridium difficile-Associated Enteropathies in Infants
Buts, J., Corthier, G., & Delmée, M. (1993) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199305000-00013 · Cited by 131
Nair, S. P., Yadav, D. K., Corpuz, M. O., & Pitchumoni, C. S. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00541.x · Cited by 130
Willey, S., & Bartlett, J. G. (1979) · Journal of Clinical Microbiology · doi:10.1128/jcm.10.6.880-884.1979 · Cited by 105
Walters, B. A. J., ROBERTS, R., Stafford, R. J., & Seneviratne, E. (1983) · Gut · doi:10.1136/gut.24.3.206 · Cited by 100
Risk Factors for Early RecurrentClostridium difficile–Associated Diarrhea
Do, A. N., Fridkin, S. K., Yechouron, A., Banerjee, S. N., Killgore, G., Bourgault, A., Jolivet, M., & Jarvis, W. R. (1998) · Clinical Infectious Diseases · doi:10.1086/513952 · Cited by 82
Biotherapeutic Agents and Infectious Diseases
(1999) · Humana Press eBooks · doi:10.1007/978-1-59259-711-6 · Cited by 33
Cited by
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
Metadata
- Authors
- Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., Garcia, R. J., Brandmarker, S., Bowen, K., Borjal, D., & Elmer, G. W.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-10
- Volume
- 31
- Issue
- 4
- Pages
- 1012-1017
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2128175074
- Cited by
- 529
- References
- 28
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.